Spiridon Konitsiotis

598 total citations
31 papers, 455 citations indexed

About

Spiridon Konitsiotis is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Spiridon Konitsiotis has authored 31 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 11 papers in Cellular and Molecular Neuroscience and 5 papers in Cognitive Neuroscience. Recurrent topics in Spiridon Konitsiotis's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (11 papers) and Dementia and Cognitive Impairment Research (4 papers). Spiridon Konitsiotis is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (11 papers) and Dementia and Cognitive Impairment Research (4 papers). Spiridon Konitsiotis collaborates with scholars based in Greece, United States and Italy. Spiridon Konitsiotis's co-authors include Thomas N. Chase, Leo Verhagen Metman, Christos Tsironis, Sofia Tsouli, Sofia Pappa, George Apostolou, Maria Chondrogiorgi, Francesco Bibbiani, Holly A. Shill and William Bara‐Jimenez and has published in prestigious journals such as Psychopharmacology, European Journal of Pharmacology and Movement Disorders.

In The Last Decade

Spiridon Konitsiotis

29 papers receiving 441 citations

Peers

Spiridon Konitsiotis
Comparison fields: 5 of 68
  • Neurology 332
  • Cellular and Molecular Neuroscience 166
  • Psychiatry and Mental health 56
  • Cognitive Neuroscience 56
  • Molecular Biology 47
Kamil G. Laban Netherlands
S. Wenger Austria
Olga Ulmanová Czechia
Sygrid van der Zee Netherlands
Jerry L. Morris United States
Susanna Jakobson Mo Sweden
Niyatee Samudra United States
Guanglu Li China
Ignacio Aracil‐Bolaños Spain
Beniamino Giordano United Kingdom
Kamil G. Laban Netherlands View profile →
Citations per field, relative to Spiridon Konitsiotis
Spiridon Konitsiotis · 1×
Citations per year, relative to Spiridon Konitsiotis
Spiridon Konitsiotis · 1×

Countries citing papers authored by Spiridon Konitsiotis

Since Specialization
Citations

This map shows the geographic impact of Spiridon Konitsiotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spiridon Konitsiotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spiridon Konitsiotis more than expected).

Fields of papers citing papers by Spiridon Konitsiotis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spiridon Konitsiotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spiridon Konitsiotis. The network helps show where Spiridon Konitsiotis may publish in the future.

Co-authorship network of co-authors of Spiridon Konitsiotis

This figure shows the co-authorship network connecting the top 25 collaborators of Spiridon Konitsiotis. A scholar is included among the top collaborators of Spiridon Konitsiotis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spiridon Konitsiotis. Spiridon Konitsiotis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 A narrative review of serum biomarkers in progressive supranuclear palsy, corticobasal syndrome, and related disorders Journal of Neural Transmission Spiridon Konitsiotis, Chrissa Sioka et al. 1
2 A new paradigm for neurodegenerative diseases classification: A clinical perspective Journal of Clinical Neuroscience Spiridon Konitsiotis et al. 3
3 Nutritional and dietary clinical trials for Parkinson's disease: a narrative review Journal of Neural Transmission Maria Chondrogiorgi, Spiridon Konitsiotis et al. 3
4 Adaptation and validation of the Greek version of the Communication and Language Assessment questionnaire for persons with Multiple Sclerosis (CLAMS) Archives of Clinical Neuropsychology Grigorios Nasios, Αναστασία Νούσια et al. 1
5 Cognitive impairment in Parkinson’s disease and other parkinsonian syndromes Journal of Neural Transmission Chrissa Sioka, Spiridon Konitsiotis et al. 3
6 Trigeminal neuralgia, demyelinating polyneuropathy, and central nervous system involvement in a patient with an SH3TC2 mutation Laboratory Medicine Christos Sidiropoulos, Spiridon Konitsiotis et al. 0
7 The evolution of comprehensive genetic analysis in neurology: Implications for precision medicine Journal of the Neurological Sciences Eirini Papadopoulou, Spiridon Konitsiotis et al. 7
8 Symbol Digit Modalities Test: Greek Normative Data for the Oral and Written Version and Discriminative Validity in Patients with Multiple Sclerosis Archives of Clinical Neuropsychology Lambros Messinis, Christos Bakirtzis et al. 10
9 Levodopa-induced dyskinesia in Parkinson’s disease: still no proof? A meta-analysis Journal of Neural Transmission Maria Chondrogiorgi, Christos Tsironis et al. 5
10 Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson’s disease patients Brain Imaging and Behavior Maria Chondrogiorgi, Loukas G. Astrakas et al. 28
11 Multimodal imaging evaluation of excessive daytime sleepiness in Parkinson's disease International Journal of Neuroscience Maria Chondrogiorgi, Loukia C. Tzarouchi et al. 24
12 Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias Expert Review of Neurotherapeutics Pantelis Stathis, Spiridon Konitsiotis et al. 12
13 Clinical characteristics of Parkinson's disease patients in Greece: A multicenter, nation-wide, cross-sectional study Journal of the Neurological Sciences Spiridon Konitsiotis, Sevasti Bostantjopoulou et al. 12
14 Effects of Amantadine on Tardive Dyskinesia Clinical Neuropharmacology Sofia Pappa, Sofia Tsouli et al. 68
15 The course of dyskinesia induction by different treatment schedules of levodopa in Parkinsonian rats: Is continuous dopaminergic stimulation necessary? Movement Disorders Christos Tsironis, Μάριος Μαρσέλος et al. 11
16 Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: Independent features or components of the same phenomenon? Behavioural Brain Research Spiridon Konitsiotis, Christos Tsironis 24
17 Effects of N-methyl-d-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesias Psychopharmacology Spiridon Konitsiotis, Christos Tsironis et al. 12
18 Continuous Transdermal Dopaminergic Stimulation in Advanced Parkinson's Disease Clinical Neuropharmacology Leo Verhagen Metman, Carrie M. Farmer et al. 78
19 Pathophysiology of motor response complications in Parkinson's disease: Hypotheses on the why, where, and what Movement Disorders Leo Verhagen Metman, Spiridon Konitsiotis et al. 77
20 Topography of dopamine D-1 and D-2 receptor-mediated rotation after intrastriatal injections of dopamine-related drugs in normosensitive rats European Journal of Pharmacology Spiridon Konitsiotis, E. Kafetzopoulos 8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026